Drawing for RESTORBIO

USPTO serial 88367175

RESTORBIO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FAUCETTE, MAX CLIFFORD STE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RESTORBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa M. Tittemore

Lisa M. Tittemore Sunstein LLP100 High StreetBoston, MA 02110UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Housemark for pharmaceutical preparations, namely, pharmaceutical preparations for assessment, treatment, and prophylaxis of osteoarthritis, ophthalmic disease, pulmonary disease, liver disease, kidney disease, neurological disease, cognitive impairment, and mitochondrial health; pharmaceutical preparations for assessment, treatment, and prophylaxis for the health problems arising from the decline in organ systems, the immune system, and neurologic and cardiac function, respiratory tract infections, respiratory illness, immunosenescence, Parkinson's Disease, urinary tract infections, and heart disease; pharmaceutical preparations for assessment, treatment, and prophylaxis of diseases, disorders, and degenerative conditions associated with aging; pharmaceutical preparations for assessment, treatment, and prophylaxis of chronic diseases, conditions and functional disorders; pharmaceutical preparations for mitigation of aging, treatment of immunological diseases and degenerative conditions of the body, promotion of life extension, and restoration of bodily functions; pharmaceutical preparations for skin care; vaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 8, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 8, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 19, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 17, 2020EX1GSOU EXTENSION 1 GRANTED—
Jun 17, 2020EXT1SOU EXTENSION 1 FILED—
Jun 17, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 7, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 12, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 4, 2019ALIEASSIGNED TO LIE—
Sep 30, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 23, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 23, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 23, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 17, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 17, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 17, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2019DOCKASSIGNED TO EXAMINER—
Apr 19, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 5, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance